Francisella tularensis has a significant extracellular phase in infected mice

Journal of Infectious Diseases

Volumn 196, Issue 1, 2007, Pages 134-137

  Forestal, Colin A ^a   Malik, Meenakshi ^b   Catlett, Sally V ^b   Savitt, Anne G ^a   Benach, Jorge L ^a   Sellati, Timothy J ^b   Furie, Martha B ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BLOOD SAMPLING; CONTROLLED STUDY; EXTRACELLULAR SPACE; FRANCISELLA TULARENSIS; HOST; INOCULATION; LEUKOCYTE; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TULAREMIA;

ANIMALS; BACTEREMIA; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FRANCISELLA TULARENSIS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; LEUKOCYTES; MICE; MICE, INBRED C3H; MICROSCOPY, FLUORESCENCE; PLASMA; TULAREMIA;

EID: 34250831089     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/518611     Document Type: Article

References (13)

1. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002; 8:225-30.
2. Sjostedt A. Intracellular survival mechanisms of Francisella tularensis, a stealth pathogen. Microbes Infect 2006; 8:561-7.
3. Fortier AH, Green SJ, Polsinelli T, et al. Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. Immunol Ser 1994; 60:349-61.
4. Long GW, Oprandy JJ, Narayanan RB, Fortier AH, Porter KR, Nacy CA. Detection of Francisella tularensis in blood by polymerase chain reaction. J Clin Microbiol 1993; 31:152-4.
5. Forestal CA, Benach JL, Carbonara C, Italo JK, Lisinski TJ, Furie MB. Francisella tularensis selectively induces proinflammatory changes in endothelial cells. J Immunol 2003; 171:2563-70.
6. Hepburn MJ, Purcell BK, Lawler JV, et al. Live vaccine strain Francisella tularensis is detectable at the inoculation site but not in blood after vaccination against tularemia. Clin Infect Dis 2006; 43:711-6.
7. Khoury JA, Bohl DL, Hersh MJ, Argoudelis AC, Brennan DC. Tularemia in a kidney transplant recipient: an unsuspected case and literature review. Am J Kidney Dis 2005; 45:926-9.
8. Elkins KL, Rhinehart-Jones TR, Culkin SJ, Yee D, Winegar RK. Minimal requirements for murine resistance to infection with Francisella tularensis LVS. Infect Immun 1996; 64:3288-93.
9. Duckett NS, Olmos S, Durrant DM, Metzger DW. Intranasal interleukin-12 treatment for protection against respiratory infection with the Francisella tularensis live vaccine strain. Infect Immun 2005; 73:2306-11.
10. Bolger CE, Forestal CA, Italo JK, Benach JL, Furie MB. The live vaccine strain of Francisella tularensis replicates in human and murine macrophages but induces only the human cells to secrete proinflammatory cytokines. J Leukoc Biol 2005; 77:893-7.
11. Rhinehart-Jones TR, Fortier AH, Elkins KL. Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells. Infect Immun 1994; 62:3129-37.
12. Fulop M, Mastroeni P, Green M, Titball RW. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine 2001; 19:4465-72.
13. Conlan JW, Shen H, Webb A, Perry MB. Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen. Vaccine 2002; 20:3465-71.